Viatris Inc (VTRS) Stock Price Today
Aura AI Summary
Key Stats
- $19.37BMarket Cap
- -Volume
- HealthSector
- $17.8652W High
- $9.4952W Low
- -Typical Hold Time
- $31.48BEnterprise Value
- 2.85%Div Yield
- -Trading Activity
Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.49 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Most Recent News
Nvidia acts like a nation-state, investing heavily in AI to secure long-term growth and market dominance.
Nvidia is strategically investing in the AI ecosystem by subsidizing major AI infrastructure projects, similar to how a nation-state might operate. This approach is aimed at expanding its future market and creating a strong competitive moat. Early si...
US-Iran conflict settles into prolonged standoff with economic pressure as main US strategy.
Six months after the US and Israel launched combat operations in Iran, the conflict remains a stalemate with no clear resolution. The Trump administration has shifted from military action to economic pressure, including secondary sanctions, aiming to...
OpenAI launches ads on ChatGPT in India to boost revenue before 2027 IPO
OpenAI has introduced advertisements on ChatGPT for free users and those on its low-cost 'Go' plan in India, one of its largest markets. This move aims to increase revenue ahead of its planned 2027 public listing and support broader access through fr...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.